DANESE, SILVIO
 Distribuzione geografica
Continente #
EU - Europa 16.062
AS - Asia 15.987
NA - Nord America 13.835
SA - Sud America 5.583
Continente sconosciuto - Info sul continente non disponibili 1.054
AF - Africa 442
OC - Oceania 32
AN - Antartide 1
Totale 52.996
Nazione #
US - Stati Uniti d'America 12.998
RU - Federazione Russa 9.215
SG - Singapore 5.252
BR - Brasile 4.609
CN - Cina 4.420
HK - Hong Kong 2.335
IT - Italia 1.829
VN - Vietnam 1.806
SE - Svezia 1.494
FR - Francia 870
BD - Bangladesh 670
DE - Germania 593
FI - Finlandia 427
GB - Regno Unito 391
AR - Argentina 365
CA - Canada 356
RO - Romania 296
IN - India 263
ID - Indonesia 212
NL - Olanda 190
AT - Austria 177
MX - Messico 172
EC - Ecuador 171
JP - Giappone 161
ZA - Sudafrica 149
IQ - Iraq 131
TR - Turchia 122
CO - Colombia 119
ES - Italia 107
PY - Paraguay 92
PL - Polonia 89
CZ - Repubblica Ceca 86
VE - Venezuela 76
PK - Pakistan 74
MA - Marocco 68
UZ - Uzbekistan 66
UA - Ucraina 62
EG - Egitto 60
JM - Giamaica 59
SA - Arabia Saudita 56
IE - Irlanda 54
CL - Cile 53
MY - Malesia 46
PE - Perù 42
UY - Uruguay 42
CR - Costa Rica 38
TN - Tunisia 38
TT - Trinidad e Tobago 38
HN - Honduras 35
NP - Nepal 35
AE - Emirati Arabi Uniti 33
DZ - Algeria 32
PH - Filippine 30
AU - Australia 29
IL - Israele 28
JO - Giordania 28
AZ - Azerbaigian 27
GT - Guatemala 25
KE - Kenya 25
DO - Repubblica Dominicana 24
IR - Iran 21
PT - Portogallo 21
SV - El Salvador 20
TW - Taiwan 20
KR - Corea 19
NI - Nicaragua 19
KZ - Kazakistan 18
LT - Lituania 18
BE - Belgio 17
OM - Oman 17
MD - Moldavia 16
AL - Albania 15
KW - Kuwait 14
PA - Panama 14
BG - Bulgaria 13
CH - Svizzera 13
RS - Serbia 13
BH - Bahrain 12
SN - Senegal 12
ET - Etiopia 11
BO - Bolivia 10
GR - Grecia 10
LB - Libano 10
TH - Thailandia 10
BB - Barbados 9
EU - Europa 9
CI - Costa d'Avorio 8
BY - Bielorussia 7
CY - Cipro 7
SI - Slovenia 7
HU - Ungheria 6
KH - Cambogia 6
NG - Nigeria 6
PR - Porto Rico 6
PS - Palestinian Territory 6
XK - ???statistics.table.value.countryCode.XK??? 6
BZ - Belize 5
KG - Kirghizistan 5
LV - Lettonia 5
LY - Libia 5
Totale 51.856
Città #
Hong Kong 2.298
Moscow 2.267
Singapore 2.189
Ashburn 1.325
Dallas 1.181
San Jose 1.054
Council Bluffs 929
Hefei 841
Shanghai 800
Lauterbourg 725
Lawrence 704
Princeton 700
Ho Chi Minh City 699
New York 582
Beijing 566
Santa Clara 436
Hanoi 386
São Paulo 366
Helsinki 350
Los Angeles 344
Milan 324
Nuremberg 156
Rome 146
Rio de Janeiro 143
Orem 142
Chicago 116
Atlanta 115
Munich 109
Montreal 99
Brasília 93
Brooklyn 91
Tokyo 90
Belo Horizonte 88
Seattle 86
London 83
Vienna 80
Campinas 76
Da Nang 76
Boston 75
Olomouc 75
Frankfurt am Main 74
Haiphong 74
Phoenix 74
Curitiba 73
Denver 73
Porto Alegre 72
Warsaw 70
Houston 67
Buffalo 65
Johannesburg 65
Naples 61
Tashkent 61
Guangzhou 58
Salvador 58
Chennai 57
Manchester 56
San Francisco 56
Boardman 55
Guayaquil 55
Quito 55
Toronto 55
Stockholm 54
Biên Hòa 53
Mexico City 51
Baghdad 50
Bologna 50
Dhaka 49
Buenos Aires 48
Dublin 47
Miami 47
Poplar 47
Guarulhos 43
Lappeenranta 42
Amsterdam 41
Philadelphia 41
Turin 38
Hangzhou 37
Mumbai 37
Ribeirão Preto 37
Hải Dương 36
Kingston 36
Cape Town 35
Montevideo 35
Asunción 34
Goiânia 34
Lima 32
Manaus 32
Tianjin 32
Istanbul 31
Jakarta 31
Recife 31
Santo André 31
Thái Bình 31
Ankara 30
Sorocaba 30
Borås 29
Brescia 29
Fortaleza 29
Turku 28
Baku 27
Totale 23.814
Nome #
Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease 1.753
The Dual Lens of Endoscopy and Histology in the Diagnosis and Management of Eosinophilic Gastrointestinal Disorders—A Comprehensive Review 750
Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines 470
Predictive value of Milan ultrasound criteria in ulcerative colitis: A prospective observational cohort study 309
Fecal, Blood, and Urinary Biomarkers in Inflammatory Bowel Diseases 262
Ustekinumab as induction and maintenance therapy for Crohn's disease 250
Inflammation and coagulation in inflammatory bowel disease: The clot thickens 216
Patient Perspectives on Biosimilars: A Survey by the European Federation of Crohn's and Ulcerative Colitis Associations 201
New Drug Delivery Systems in Inflammatory Bowel Disease: MMX (TM) and Tailored Delivery to the Gut 178
VAC-Stent in the Treatment of Post-Esophagectomy Anastomotic Leaks: A New “Kid on the Block” Who Marries the Best of Old Techniques—A Review 177
Predictive Value of Bowel Ultrasound in Crohn's Disease: A 12-Month Prospective Study 166
Extraintestinal Manifestations in Inflammatory Bowel Disease: From Pathophysiology to Treatment 158
The Endoscopic Management of Zenker’s Diverticulum: A Comprehensive Review 155
Endoscopic Vacuum Therapy (EVT) versus Self-Expandable Metal Stent (SEMS) for Anastomotic Leaks after Upper Gastrointestinal Surgery: Systematic Review and Meta-Analysis 152
Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches 150
VAGUS NERVE STIMULATION REDUCES DISEASE ACTIVITY AND MODULATES SERUM AND AUTONOMIC BIOMARKERS IN BIOLOGICREFRACTORY CROHN'S DISEASE 150
Long-term Efficacy of Vedolizumab for Crohn's Disease 150
Crohn's disease 147
Budesonide : teaching an old dog new tricks for inflammatory bowel disease treatment 147
Correction to: Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management 136
Histological Scores in Patients with Inflammatory Bowel Diseases: The State of the Art 133
Unraveling the pathogenesis of Barrett’s esophagus and esophageal adenocarcinoma: the “omics” era 129
Critical role of the CD40-CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease 127
Inflammation and malnutrition in inflammatory bowel disease 126
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial 125
Adalimumab in Crohn's disease : tips and tricks after 5 years of clinical experience 124
Endoscopic Treatment Approaches for Inflammatory Bowel Diseases: Old Friends and New Weapons 123
A Comprehensive Multidisciplinary Approach to Diagnosing Chronic Inflammatory Bowel Diseases: Integration of Clinical, Endoscopic, and Imaging Modalities 123
Gut Microbiota Metabolites: Unveiling Their Role in Inflammatory Bowel Diseases and Fibrosis 121
Unlocking hope: The future of ustekinumab biosimilars in Crohn's disease treatment 121
Ulcerative colitis: Impact of early disease clearance on long-term outcomes - A multicenter cohort study 121
Advancing Colorectal Cancer Prevention in Inflammatory Bowel Disease (IBD): Challenges and Innovations in Endoscopic Surveillance 120
Gastrointestinal Ultrasound in Infectious Diseases: A Comprehensive Review 120
Balanced propofol sedation administered by nonanesthesiologists : the first Italian experience 117
Venous Thromboembolism in Patients with Neuroendocrine Neoplasms: A Systematic Review of Incidence, Types, and Clinical Outcomes 116
Bowel ultrasound score is accurate in assessing response to therapy in patients with Crohn's disease 115
Efficacy and Safety of S1P1 Receptor Modulator Drugs for Patients with Moderate-to-Severe Ulcerative Colitis 115
The role of filgotinib in ulcerative colitis and Crohn's disease 113
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes 113
The Endoscopic Management of Anastomotic Strictures After Esophagogastric Surgery: A Comprehensive Review of Emerging Approaches Beyond Endoscopic Dilation 112
Bowel ultrasound in inflammatory bowel disease: How far in the grayscale? 111
Inflammatory Bowel Disease and Colorectal Cancer 111
Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa 110
Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study 110
The Role of IL-23 Inhibitors in Crohn’s Disease 109
Imaging in Gastroparesis: Exploring Innovative Diagnostic Approaches, Symptoms, and Treatment 108
Endoscopic vacuum therapy versus self-expandable metal stent for treatment of anastomotic leaks < 30 mm following oncologic Ivor-Lewis esophagectomy: a matched case-control study 107
Clinical and biological heterogeneity of Grade 2 digestive neuroendocrine neoplasms: prognostic significance of the 10% Ki-67 index cutoff and implications for treatment strategies. A longitudinal study 106
Accuracy of a new diagnostic tool in deep infiltrating endometriosis: Positron emission tomography-computed tomography with 16 alpha-[18F]fluoro-17 beta-estradiol 104
Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment—insights from Phase II and III trials 104
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis 102
Endoscopic Management of Post-Esophagectomy Delayed Gastric Conduit Emptying (DGCE): Results from a Cohort Study in a Tertiary Referral Center with Comparison between Procedures 102
Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study 101
Advances in Endo-Hepatology: The Role of Endoscopic Ultrasound in the Management of Portal Hypertension 100
Effect of mesenteric sparing or extended resection in primary ileocolic resection for Crohn's disease on postoperative endoscopic recurrence (SPICY): an international, randomised controlled trial 100
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience 100
New therapeutic avenues in ulcerative colitis: thinking out of the box 100
Endoscopic Submucosal Dissection (ESD) for the Management of Fibrotic Non-Lifting Colorectal Lesions (NLCLs): Results from a Large Multicenter Retrospective Study 99
Advances in pharmacotherapy for ulcerative colitis: a focus on JAK1 inhibitors 99
Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response 99
A PROLONGED FOLLOW-UP ON THE EFFICACY AND SAFETY OF INFLIXIMAB BIOSIMILAR CT-P13 IN IBD ACROSS ITALY: THE PROSIT COHORT 99
A liophylized and inactivated colture of Lactobacillus acidophilus increases Helicobacter pylori eradication rate 99
The role of diet and lifestyle in early-onset colorectal cancer: A systematic review 99
The Role of Vitamin D in Inflammatory Bowel Diseases: From Deficiency to Targeted Therapeutics and Precise Nutrition Strategies 98
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease 97
A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies 97
Role of Probiotics in the Management of Patients with Ulcerative Colitis and Pouchitis 96
Dual-channel endoscope for double-traction endoscopic device-assisted full-thickness resection of rectal superficial tumor 96
Multiple Ileal and Colonic Stenoses: Is It Always Crohn’s Disease? 95
Targeting mucosal healing in Crohn’s disease: efficacy of novel pathways and therapeutic targets 95
Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting 94
Correction to: Understanding the therapeutic toolkit for inflammatory bowel disease (Nature Reviews Gastroenterology & Hepatology, (2025), 22, 6, (371-394), 10.1038/s41575-024-01035-7) 94
A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis 94
An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study 93
Carcinomas in inflammatory bowel disease: a narrative review on diagnostic imaging techniques 93
Clinical Pathologic Challenge Saxophone Penis: Challenge 93
A PROSPECTIVE, SINGLE CENTER STUDY OF ENDOSCOPIC SUBMUCOSAL DISSECTION OF RECTAL LST LESIONS > 3 CM BY USING AN INNOVATIVE CONCEPT OF INJECTING AND CUTTING: THE WATER-JET HYBRID-KNIFE (ESD-H) 93
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial 92
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations 92
The Role of Fecal Microbiota Transplantation in IBD 91
Prevalence, characteristics, management, and outcomes of difficult-to-treat inflammatory bowel disease 91
New Technologies in Digestive Endoscopy for Ulcerative Colitis Patients 91
Small Bowel Cancer in Crohn’s Disease 91
A multicentre prospective cohort study assessing the effectiveness of budesonide MMX (R) (Cortiment (R)(MMX (R))) for active, mild-to-moderate ulcerative colitis 91
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 91
JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines 90
Leaving behind the Mucosa: Advances and Future Directions of Intestinal Ultrasound in Ulcerative Colitis 89
Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health response 89
Adalimumab in active ulcerative colitis: A "real-life" observational study 89
Difficult-to-treat inflammatory bowel disease: results from a global IOIBD survey 88
Evolution and New Horizons of Endoscopy in Inflammatory Bowel Diseases 88
A Prospective Comparison Between 1.5t Magnetic Resonance and 3t Magnetic Resonance in Ileo-Colonic Crohn's Disease: A Single Center Experience 88
Biological agents for ulcerative colitis : Hypes and hopes 88
Neutrophil-only Histological Assessment of Ulcerative Colitis Correlates with Endoscopic Activity and Predicts Long-Term Outcomes in a Multicentre Study 87
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials 86
HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis 86
Involvement of CD40-CD40 Ligand in Uncomplicated and Refractory Celiac Disease 86
Calcium supplementation for the prevention of colorectal adenomas: a systematic review and meta-analysis of randomized controlled trials 85
WallFlex colonic stent placement for management of malignant colonic obstruction : a prospective study at two centers 85
Internet use among inflammatory bowel disease patients: an Italian multicenter survey 85
Totale 14.237
Categoria #
all - tutte 334.724
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 334.724


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022961 0 0 0 810 16 17 7 5 23 23 15 45
2022/20233.362 1.824 645 74 12 14 363 54 136 179 20 13 28
2023/20241.129 31 38 62 52 54 196 26 70 2 45 107 446
2024/202510.277 1.159 43 133 88 80 659 1.838 1.057 1.983 1.802 653 782
2025/202633.613 2.473 2.248 2.300 4.520 2.224 841 2.412 2.146 8.381 1.567 2.056 2.445
2026/20273.651 1.791 1.860 0 0 0 0 0 0 0 0 0 0
Totale 52.996